Plasmodium falciparum is the causative agent of one type of malaria known as malignant tertian malaria (p. 125) in which the vector is a female mosquito of the genus Anopheles.

Who funded malaria vaccine?

Researchers have been developing and testing the RTS,S vaccine — also known by its brand name, Mosquirix — since 1987, at a cost of more than US$750 million. This was funded mainly by the Bill & Melinda Gates Foundation in Seattle, Washington, and the London-based pharmaceutical firm GlaxoSmithKline (GSK).

What is the name of the world’s first malaria vaccine?

RTS,S/ASO1 (RTS. S), trade name Mosquirix, which was endorsed by the World Health Organisation (WHO) on Wednesday (October 6), is the first and, to date only, vaccine shown to have the capability of significantly reducing malaria, and life-threatening severe malaria, in tests on young African children.

What is the difference between Tertian and Quartan malaria?

Tertian and quartan fevers are due to the cyclic lysis of red blood cells that occurs as trophozoites complete their cycle in erythrocytes every 2 or 3 days, respectively. P malariae causes quartan fever; P vivax and P ovale cause the benign form of tertian fever, and P falciparum causes the malignant form.

What is benign tertian malaria?

Plasmodium vivax usually causes an acute self-limiting febrile illness with fever spikes on every third day and no complications or death. Therefore the illness caused by this parasite was termed benign tertian malaria.

How much did Bill Gates donate to malaria?

Perkin, M.D. SEATTLE — PATH (Program for Appropriate Technology in Health), a Seattle-based nonprofit, announced today that Bill and Melinda Gates have donated $50 million to support a new Malaria Vaccine Initiative.

Why is there no vaccine for malaria?

The development of a malaria vaccine has faced several obstacles: the lack of a traditional market, few developers, and the technical complexity of developing any vaccine against a parasite. Malaria parasites have a complex life cycle, and there is poor understanding of the complex immune response to malaria infection.